Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Scopolamine (Devil's Breath)

Is Scopolamine (Devil's Breath) legal in Germany?

Also known as: hyoscine

Confirmed against a primary sourceVerified September 21, 2026
Legal status
Scopolamine is not scheduled in Germany, and the rejection recorded on this row is a pharmacological one rather than a chemical one. The search ran on 20 September 2026 under „Scopolamin; Scopolamine; Hyoscin“ across BtMG Anlagen I bis III and NpSG Anlagen 1 und 2 and returned no entry under any of the three names. The dossier then disposes of the argument from resemblance: near terms such as Cocain or Atropin do not substitute for a printed entry for this alkaloid. That matters because the substance shares a tropane skeleton with a listed narcotic, and the shared skeleton is exactly the reasoning the row refuses. The regime that applies instead is medicines law, which governs the product rather than the molecule.
Consequences if caught
Capital exposure: none. Germany has no death penalty. There is no narcotics ceiling either, because the dossier's finding is a confirmed absence from the lists and no maximum can be derived from a substance not being in them. The particular discipline here is not to borrow the penalty that attaches to the tropane alkaloid that is listed: that figure belongs to that entry, and a shared ring system is not a shared listing. What exposure exists is a medicines and product exposure, and the dossier does not quantify it.
If prescribed or medical
There is no narcotics placement to attach a traveller rule to, so a patch or tablet containing this alkaloid travels as an ordinary medicine rather than as a controlled drug. Whether a particular preparation is a medicinal product at all is settled by the medicines definition on the product's purpose and presentation. The dossier records no German prescription rule and no traveller rule, so this cell defers on both.
Documentation
Carry any medicinal preparation in its dispensing packaging with the prescription, which answers the only question that arises, namely whether the product is an authorised medicine dispensed to the holder. The search was run on 20 September 2026 and the absence holds as at that text.
Primary sources
  • Germany, confirmed absence from Betäubungsmittelgesetz Anlagen I bis III and Neue-psychoaktive-Stoffe-Gesetz Anlagen 1 und 2 on the terms „Scopolamin
  • Scopolamine
  • Hyoscin“, with the nearby tropane alkaloid entries considered and rejected as different substances
  • read at the Anlage pages on https://www.gesetze-im-internet.de/ on 20 September 2026
  • the governing route is medicines law at AMG §§ 2 and 21

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Other substances confirmed in Germany

Same substance, other countries